Literature DB >> 28791046

Corrigendum to "Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences".

Giuseppina T Russo1, Annalisa Giandalia1, Elisabetta L Romeo1, Nunziata Morabito1, Marco Muscianisi1, Maria Concetta Ruffo1, Antonino Catalano1, Domenico Cucinotta1.   

Abstract

[This corrects the article DOI: 10.1155/2016/1615735.].

Entities:  

Year:  2017        PMID: 28791046      PMCID: PMC5534273          DOI: 10.1155/2017/4576102

Source DB:  PubMed          Journal:  Int J Endocrinol        ISSN: 1687-8337            Impact factor:   3.257


In the article titled “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences” [1], with regard to the FRAX® tool, it has been reported that “Among the different tools to assess fracture risk, the WHO fracture risk assessment (FRAX) is a computer based algorithm (http://www.shef.ac.uk/FRAX/) primarily intended for use in primary care [56, 57].” We point out that the metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2]. Additionally, the name of the fourth author was given incorrectly as Morabito Nunziata. The author's name should have been written as Nunziata Morabito. The revised authors' list is shown above.
  2 in total

Review 1.  Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences.

Authors:  Giuseppina T Russo; Annalisa Giandalia; Elisabetta L Romeo; Morabito Nunziata; Marco Muscianisi; Maria Concetta Ruffo; Antonino Catalano; Domenico Cucinotta
Journal:  Int J Endocrinol       Date:  2016-12-04       Impact factor: 3.257

2.  Clarifying WHO's position on the FRAX® tool for fracture prediction.

Authors:  Nathan Ford; Susan L Norris; Suzanne R Hill
Journal:  Bull World Health Organ       Date:  2016-12-01       Impact factor: 9.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.